Business Standard

Ishita Drugs & Industries Share Price

Know More
BSENSE

64.11-1.64 (-2.49%)

12:00 AM,24th May 2024
Stock not traded

BSE : 524400

NSE :

Sector : Health care

ISIN Code : INE806D01016

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 24-May-2024 | 12:00 AM IST

Market Cap (₹ Cr)

19

Turnover (₹ Cr)

0.00

Volume (Shares)

453

Face Value

10

52-WK High

98.37

52-WK High Date

02-Feb-2024

52-WK Low

50.61

52-WK Low Date

09-Jun-2023

All Time High

98.37

All Time High Date

02-Feb-2024

All Time Low

0.10

All Time Low Date

05-Dec-1997

Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Limited was incorporated in Feb.'92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients drug intermediates fine chemicals and excipient. It has a state-of-art manufacturing facility in terms of reaction capabilities quality control and environmental safety. The plant has been designed and constructed to meet GMP norms.The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plan...
Read More

Ishita Drugs Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>ISHITA DRUGS & INDUSTRIES LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24231GJ1992PLC017054</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Srushti Pandya <br/> Designation: Company Secretary <br/> EmailId: ishitadrugs@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Sumit Agrawal <br/> Designation: Chief Financial Officer <br/> EmailId: ishitadrugs@gmail.com</div> </div> <div> <br/> Date: 25/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

View More

Ishita Drugs & Industries Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

19

EPS - TTM (₹) [S]

2.16

P/E Ratio (X) [S]

2.01

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]31.84
P/B Ratio (₹) [S]2.01

Funds Owing this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

Date Broker Action Prices(₹) Report
Data Not Found

Stock Strength

Today's Low/High

64.07

64.11

Week Low/High

63.50

68.00

Month Low/High

63.25

72.00

Year Low/High

50.61

98.00

All time Low/High

0.10

98.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-2.72%%2.322.19%
1 Month-11.40%%2.572.63%
3 Month-18.93%%3.403.35%
6 Month-7.72%%14.6415.98%
1 Year11.03%%22.4325.55%
3 Year102.24%%49.3251.06%

Company Info

Company Information

Managing Director : Jagdish Agrawal

Director : Govind Gupta

Non Executive Director : Abha Agrawal

Director : Niranjan Agrawal

Director : Arvind Sapkal

Company Sec. & Compli. Officer : Srushti Pandya

Registered Office: Survey No 179/1 Taluka Sanand, Village Vasna-Iyava,Ahmedabad,Gujarat-382170 Ph:

Email:ishitadrugs@vsnl.net

URL:http://www.ishitadrugs.com

FAQs about Ishita Drugs & Industries Ltd

1. What's the Ishita Drugs & Industries Ltd share price today?
Ishita Drugs & Industries Ltd share price was Rs 64.11 at close on 24th May 2024. Ishita Drugs & Industries Ltd share price was down by 2.49% from the previous closing price of Rs 65.75. Ishita Drugs & Industries Ltd share price trend:

  • Last 1 Month: Ishita Drugs & Industries Ltd share price moved down by 11.40% on BSE
  • Last 3 Months: Ishita Drugs & Industries Ltd share price moved down by 18.93% on BSE
  • Last 12 Months: Ishita Drugs & Industries Ltd share price moved up by 11.03% on BSE
  • Last 3 Years: Ishita Drugs & Industries Ltd price moved up by 102.24% on BSE


2. How can I quickly analyse the performance of the Ishita Drugs & Industries Ltd stock?
The performance of the Ishita Drugs & Industries Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 29.68
  • Price to book value ratio is 2.01
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Ishita Drugs & Industries Ltd stock is Rs 2.16


3. What is the market cap of Ishita Drugs & Industries Ltd?
Ishita Drugs & Industries Ltd has a market capitalisation of Rs 19 crore.


4. What is Ishita Drugs & Industries Ltd's 52-week high/low share price?
The Ishita Drugs & Industries Ltd’s 52-week high share price is Rs 98.37 and 52-week low share price is Rs 50.61.


5. Is the Ishita Drugs & Industries Ltd profitable?
On a consolidated basis, Ishita Drugs & Industries Ltd reported a profit of Rs 0.12 crore on a total income of Rs 3.22 crore for the quarter ended 2023. For the year ended Dec 2023, Ishita Drugs & Industries Ltd had posted a profit of Rs 0.12 crore on a total income of Rs 3.22 crore.


6. Which are Ishita Drugs & Industries Ltd’s peers in the Health care sector?
Ishita Drugs & Industries Ltd’s top 5 peers in the Health care sector are Phaarmasia, Zenith Health, Colinz Labs, Ishita Drugs, Beryl Drugs, Ortin Labs., Decipher Labs.


7. Who owns how much in Ishita Drugs & Industries Ltd?
Key changes to the Ishita Drugs & Industries Ltd shareholding are as follows:

  • Promoter holding in Ishita Drugs & Industries Ltd has gone up to 49.42 per cent as of Mar 2024 from 49.38 per cent as of Jun 2023.